Surprisingly, The National Agency of Drug and Food Control (BPOM) gave the gesture to directing the clinical test for Ivermectin to assess its viability and wellbeing for treating COVID-19 patients in Indonesia. Certainly, with the endorsement, the clinical preliminary of Ivermectin as a COVID-19 medication can be directed soon. This is what BPOM head Penny K. Lukito expressed during a virtual public interview.
The endorsement was given based on a few contemplations, including the illness transmission circumstance, worldwide distribution on Ivermectin use, and the World Health Organization‘s (WHO’s) rules on treatment for COVID-19 patients.
The clinical preliminary is wanted to be led at eight emergency clinics: Persahabatan Hospital, Prof. Dr. Sulianti Saroso Infectious Disease Hospital, Gatot Subroto Army Hospital, Dr. Esnawan Antariksa Air Force Hospital, Suyoto Hospital, and Wisma Atlet Emergency Hospital for COVID-19 in Jakarta just as Soedarso Hospital in Pontianak, West Kalimantan, and Adam Malik Hospital in Medan, North Sumatra.
For patients needing this medication yet can’t partake in the clinical preliminary, specialists can endorse this medication as per the supported conventions for clinical preliminary. Prior, the BPOM expressed that Ivermectin couldn’t yet be utilized in drug for COVID-19 patients, as the clinical preliminary information was at this point inaccessible.
They actually need to gather information on clinical test, and as of now, it was not decisive yet to help the utilization of Ivermectin for COVID-19. Lukito advised general society against buying the medication without a specialist’s remedy. As indicated by BPOM, Ivermectin 12 mg is enrolled in Indonesia for worm contamination. The medication is given in a solitary portion of 150-200 mcg for every kilogram of body weight once per year.
Looking back, It was named a professionally prescribed medication, which is accessible to general society on remedy as it were. Long haul utilization without solution could cause results, like joint torment, skin rash, fever, migraine, stoppage, looseness of the bowels, languor, and Steven-Johnson Syndrome.